Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL39 (5-HT, 5-Hydroxytryptamine, Enteramine, Serotonin, Thrombotonin) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
D1 receptor/Dopamine D1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728] | ||||||||
ChEMBL | Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells | B | 5.01 | pKd | 9690 | nM | Kd | J Med Chem (1996) 39: 850-859 [PMID:8632409] |
GtoPdb | - | - | 5 | pKi | - | - | - | Nature (1991) 350: 614-9 [PMID:1826762] |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | Basal binding towards Dopamine receptor D3 was evaluated using [35S]- GTP-gamma S radioligand | B | 6.28 | pEC50 | 523 | nM | EC50 | J Med Chem (2003) 46: 3822-3839 [PMID:12930145] |
D3 receptor/Dopamine D3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3138] [GtoPdb: 216] [UniProtKB: P19020] | ||||||||
ChEMBL | Tested for binding affinity against dopamine receptor D3 expressed in Sf9 cells. | B | 5.63 | pKi | 2338 | nM | Ki | J Med Chem (1993) 36: 1499-1500 [PMID:8098771] |
MT1 receptor/Melatonin receptor 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1945] [GtoPdb: 287] [UniProtKB: P48039] | ||||||||
ChEMBL | Displacement of 2-[125I]iodomelatonin from human Melatonin receptor type 1A expressed in CHO cells | B | 4 | pKi | >100000 | nM | Ki | Bioorg Med Chem Lett (1997) 7: 2409-2414 |
MT2 receptor/Melatonin receptor 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1946] [GtoPdb: 288] [UniProtKB: P49286] | ||||||||
ChEMBL | Inhibition of 2-[125I]iodomelatonin binding to human Melatonin receptor type 1B expressed in CHO cells | B | 4 | pKi | >100000 | nM | Ki | Bioorg Med Chem Lett (1997) 7: 2409-2414 |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908] | ||||||||
ChEMBL | Binding affinity for 5-hydroxytryptamine 1A receptor was determined | B | 8.5 | pKd | 8.5 | - | pKD | J Med Chem (1993) 36: 1918-1919 [PMID:8515429] |
ChEMBL | Displacement of [3H]WAY100635 from human recombinant 5HT1A receptor | B | 5 | pKi | 10000 | nM | Ki | J Med Chem (2008) 51: 2887-2890 [PMID:18433113] |
ChEMBL | Displacement of [3H]8-OH-DPAT from 5HT1A receptor expressed in HEK293 cells after 2 hrs by liquid scintillation counting | B | 7.3 | pKi | <50 | nM | Ki | Bioorg Med Chem (2010) 18: 3345-3351 [PMID:20363635] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human recombinant 5-HT1A receptor expressed in HEK293-EBNA cells after 120 mins | B | 8.02 | pKi | 9.5 | nM | Ki | Eur J Med Chem (2013) 69: 920-930 [PMID:24161678] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in CHO-K1 cell membranes incubated for 60 mins by microbeta scintillation counting analysis | B | 8.26 | pKi | 5.5 | nM | Ki | Eur J Med Chem (2019) 183: 111736-111736 [PMID:31586817] |
ChEMBL | Displacement of [3H]8-OH-DAPT from human recombinant 5-HT1A receptor expressed in CHO cells measured after 60 to 90 mins by radioligand completion assay relative to control | B | 8.35 | pKi | 4.5 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand | B | 8.4 | pKi | 3.98 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Displacement of [3H]8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes incubated for 60 mins by microbeta scintillation counting method | B | 8.44 | pKi | 3.6 | nM | Ki | Eur J Med Chem (2019) 180: 383-397 [PMID:31325785] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from recombinant human 5HT1A receptor expressed in CHO cell membranes measured after 60 mins by microbeta scintillation counting analysis | B | 8.52 | pKi | 3 | nM | Ki | Eur J Med Chem (2019) 166: 144-158 [PMID:30703658] |
ChEMBL | In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.52 | pKi | 3 | nM | Ki | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus | B | 8.55 | pKi | 2.8 | nM | Ki | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor | B | 8.6 | pKi | 2.5 | nM | Ki | J Med Chem (1995) 38: 3602-3607 [PMID:7658447] |
ChEMBL | Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand | B | 8.61 | pKi | 2.48 | nM | Ki | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
ChEMBL | Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells | F | 8.61 | pKi | 2.48 | nM | Ki | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | Displacement of [3H]8-OH-DPAT from human 5-HT1A receptor transfected in CFO-K1 cells after 30 mins by liquid scintillation spectrometry | B | 8.68 | pKi | 2.08 | nM | Ki | Eur J Med Chem (2014) 85: 716-726 [PMID:25128671] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT | B | 8.77 | pKi | 1.7 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes after 60 mins by microbeta scintillation counting analysis | B | 8.85 | pKi | 1.4 | nM | Ki | Bioorg Med Chem (2018) 26: 527-535 [PMID:29269256] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes after 60 mins by scintillation counting | B | 8.89 | pKi | 1.3 | nM | Ki | J Med Chem (2017) 60: 7483-7501 [PMID:28763213] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes after 60 mins by scintillation counting method | B | 8.89 | pKi | 1.3 | nM | Ki | Eur J Med Chem (2017) 137: 108-116 [PMID:28575721] |
ChEMBL | Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor | B | 8.9 | pKi | 1.26 | nM | Ki | J Med Chem (2008) 51: 2887-2890 [PMID:18433113] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human recombinant 5-HT1A receptor expressed in HEK293 cells incubated for 60 mins by microbeta2 scintillation counter | B | 8.92 | pKi | 1.2 | nM | Ki | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHOK1 cell membranes after 60 mins by microbeta scintillation counting method | B | 8.96 | pKi | 1.1 | nM | Ki | Medchemcomm (2017) 8: 1690-1696 [PMID:30108880] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHOK1 cell membranes after 30 mins by liquid scintillation spectrometry | B | 9.04 | pKi | 0.91 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 4052-4056 [PMID:27396505] |
ChEMBL | Displacement of [3H]8-OH-DPAT from 5-HT1A receptor (unknown origin) expressed in HEK293 cells by liquid scintillation counter | B | 9.05 | pKi | 0.9 | nM | Ki | Bioorg Med Chem (2013) 21: 856-868 [PMID:23332346] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in HEK293 cells | B | 9.21 | pKi | 0.62 | nM | Ki | Bioorg Med Chem (2012) 20: 4862-4871 [PMID:22748706] |
GtoPdb | - | - | 9.7 | pKi | - | - | - |
Biochem J (1992) 285 ( Pt 3): 933-8 [PMID:1386736]; Eur J Pharmacol (1998) 355: 245-56 [PMID:9760039]; Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 447-53 [PMID:10431754]; Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 205-17 [PMID:9550290]; Naunyn Schmiedebergs Arch Pharmacol (1997) 355: 682-8 [PMID:9205951]; Biosci Rep (2004) 24: 101-15 [PMID:15628665] |
ChEMBL | In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.25 | pIC50 | 5.6 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1A receptor | B | 8.28 | pIC50 | 5.2 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Agonist activity at human 5HT1A receptor expressed in CHOK1 cells incubated for 16 hrs followed by forskolin-stimulation and measured after 2 hrs by dual-glo luciferase reporter gene assay | B | 5.74 | pEC50 | 1800 | nM | EC50 | J Nat Prod (2019) 82: 3302-3310 [PMID:31789520] |
ChEMBL | Agonist activity at human 5HT1A receptor expressed in C6 cells assessed as stimulation of [35S]GTPgammaS binding | F | 6.64 | pEC50 | 229.09 | nM | EC50 | J Med Chem (2007) 50: 5024-5033 [PMID:17803293] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO cells after 90 mins by beta-arrestin-2 recruitment assay | B | 6.77 | pEC50 | 169.82 | nM | EC50 | Bioorg Med Chem (2015) 23: 4824-4830 [PMID:26081758] |
ChEMBL | Agonist activity at 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay | F | 6.82 | pEC50 | 150 | nM | EC50 | Bioorg Med Chem (2009) 17: 4873-4880 [PMID:19559623] |
ChEMBL | Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding | F | 6.83 | pEC50 | 147 | nM | EC50 | J Med Chem (2010) 53: 1319-1328 [PMID:20041669] |
ChEMBL | Biased agonist activity at Gal4-VP16 transcription factor linked human 5-HT1A receptor expressed in human U2OS cells assessed as induction of beta-arrestin2 recruitment measured after 5 hrs by Tango assay | B | 6.89 | pEC50 | 128.82 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Biased agonist activity at Gal4-VP16 transcription factor linked human 5-HT1A receptor expressed in human U2OS cells assessed as stimulation of beta-arrestin recruitment measured after 5 hrs by Tango assay | B | 6.89 | pEC50 | 128.82 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO-K1 cells co-expressing Galpha16 assessed as increase in calcium mobilization measured for 30 secs by aequorin-derived luminescence assay | F | 7.01 | pEC50 | 97.7 | nM | EC50 | Bioorg Med Chem Lett (2018) 28: 2039-2049 [PMID:29730027] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO-K1 cells assessed as increase in calcium mobilization measured for 30 secs by aequorin-derived luminescence assay | F | 7.16 | pEC50 | 69.18 | nM | EC50 | Eur J Med Chem (2017) 137: 108-116 [PMID:28575721] |
ChEMBL | Biased agonist activity at human 5-HT1A receptor stably expressed in CHO-K1 cells co-expressing Galpha16/GPCR assessed as increase in calcium mobilization measured for 30 secs in presence of coelenterazine by aequorin-reporter gene based luminescence assay | F | 7.23 | pEC50 | 58.88 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Agonist activity at human recombinant 5-HT1A receptor expressed in CHOK1 cells measured after 1 hr by microbeta2 scintillation counter | B | 7.25 | pEC50 | 56.23 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Biased agonist activity at human recombinant 5-HT1A receptor stably expressed in CHO-K1 cells assessed as increase in calcium mobilization measured at 2 sec intervals for 180 secs by Fluo-4AM dye based fluorescence assay | F | 7.3 | pEC50 | 50.12 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Partial agonist activity at recombinant human 5-HT1A expressed in CHO-K1 cells by pathhunter beta-arrestin assay | B | 7.34 | pEC50 | 45.3 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127358-127358 [PMID:32631554] |
ChEMBL | Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig | F | 7.37 | pEC50 | 43 | nM | EC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
ChEMBL | Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay | B | 7.41 | pEC50 | 39 | nM | EC50 | J Med Chem (2013) 56: 4671-4690 [PMID:23675993] |
ChEMBL | Biased agonist activity at human recombinant 5-HT1A receptor stably expressed in CHO-K1 cells assessed as increase in ERK1/2 phosphorylation levels incubated for 15 mins by Alphalisa assay | B | 7.48 | pEC50 | 33.11 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Biased agonist activity at human 5-HT1A receptor stably expressed in CHO-K1 cells assessed as increase in ERK1/2 phosphorylation after 15 mins by Alphalisa assay | B | 7.48 | pEC50 | 33.11 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Biased agonist activity at human recombinant 5-HT1A receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 40 mins by LANCE Ultra cAMP kit-based TR-FRET assay | F | 7.51 | pEC50 | 30.9 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Biased agonist activity at human 5-HT1A receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 40 mins by LANCE Ultra cAMP kit-based TR-FRET assay | F | 7.51 | pEC50 | 30.9 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 15 mins by ELISA | F | 7.56 | pEC50 | 27.54 | nM | EC50 | Bioorg Med Chem (2015) 23: 4824-4830 [PMID:26081758] |
ChEMBL | Agonist activity at serotonin 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as induction of calcium flux after 60 mins by calcium 4-dye based FLIPR assay | F | 7.72 | pEC50 | 19 | nM | EC50 | J Med Chem (2018) 61: 10017-10039 [PMID:30383372] |
ChEMBL | Agonist activity at human recombinant 5HT1A receptor (unknown origin) stably expressed in CHO-K1 incubated for 30 mins by [35S]GTPgammaS binding assay | F | 7.74 | pEC50 | 18 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 126703-126703 [PMID:31627993] |
ChEMBL | Agonist activity at 5-HT1A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay | B | 7.81 | pEC50 | 15.33 | nM | EC50 | Eur J Med Chem (2016) 123: 332-353 [PMID:27487565] |
ChEMBL | Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus. | F | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S | F | 8.06 | pEC50 | 8.71 | nM | EC50 | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Agonist activity at human 5HT1A receptor expressed in CHO-K1 cells by calcium 4 dye based FLIPR assay | F | 8.24 | pEC50 | 5.8 | nM | EC50 | Eur J Med Chem (2020) 207: 112709-112709 [PMID:32877805] |
ChEMBL | Agonist activity at human 5-HT1AR expressed in CHO-K1 cells assessed as increase in calcium flux by fluorimetric method | F | 8.24 | pEC50 | 5.7 | nM | EC50 | Eur J Med Chem (2018) 145: 790-804 [PMID:29407591] |
ChEMBL | Agonist activity at human recombinant 5-HT1A receptor expressed in CHOK1 cells measured after 1 hr by microbeta2 scintillation counter | B | 8.25 | pEC50 | 5.61 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Agonist activity at 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay | F | 8.43 | pEC50 | 3.75 | nM | EC50 | Bioorg Med Chem (2013) 21: 856-868 [PMID:23332346] |
ChEMBL | Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor | B | 8.43 | pEC50 | 3.7 | nM | EC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Agonist activity at 5HT1A receptor (unknown origin) after 20 mins by [35S]GTP-gammaS binding assay | F | 8.52 | pEC50 | 3 | nM | EC50 | Bioorg Med Chem (2014) 22: 5838-5846 [PMID:25308766] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay | F | 8.69 | pEC50 | 2.03 | nM | EC50 | Eur J Med Chem (2021) 214: 113243-113243 [PMID:33582388] |
ChEMBL | Agonistic activity at human 5HT1A in CHO cells by the inhibition of forskolin-stimulated cAMP accumulation | F | 9 | pEC50 | 1 | nM | EC50 | J Med Chem (2006) 49: 125-134 [PMID:16392798] |
ChEMBL | Agonist activity assessed by stimulation of [35S]GTP-gamma-S binding to human 5HT1A receptor expressed in CHO cells | F | 9.15 | pEC50 | 0.7 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 2101-2104 [PMID:16458504] |
ChEMBL | Agonistic activity at human 5HT1A receptor by [35S]GTP-gamma-S binding | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2006) 49: 125-134 [PMID:16392798] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3737] [GtoPdb: 1] [UniProtKB: Q64264] | ||||||||
ChEMBL | Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (1990) 33: 386-394 [PMID:2136918] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL273] [GtoPdb: 1] [UniProtKB: P19327] | ||||||||
ChEMBL | Displacement of [3H]8-OH-DPAT from 5HT1A receptor in Rattus norvegicus (rat) cerebral cortex after 15 min by filter binding assay | B | 8.05 | pKi | 9 | nM | Ki | Med Chem Res (2008) 17: 507-514 |
ChEMBL | Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue. | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
ChEMBL | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement | B | 8.32 | pKi | 4.79 | nM | Ki | J Med Chem (1996) 39: 126-134 [PMID:8568799] |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain | B | 8.37 | pKi | 4.31 | nM | Ki | J Med Chem (1993) 36: 3161-3165 [PMID:8230102] |
ChEMBL | Displacement of [3H]8-OH-DPAT from rat 5HT1A receptor expressed in CHO cells | B | 8.52 | pKi | 3 | nM | Ki | Bioorg Med Chem (2008) 16: 6675-6681 [PMID:18562201] |
ChEMBL | Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand. | B | 8.52 | pKi | 3 | nM | Ki | J Med Chem (1987) 30: 1-12 [PMID:3543362] |
ChEMBL | Displacement of [3H]8OH-DPAT from 5HT1A in rat brain cerebral cortex after 15 mins by scintillation counting | B | 8.59 | pKi | 2.6 | nM | Ki | Eur J Med Chem (2011) 46: 4474-4488 [PMID:21816515] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from rat cerebral cortex 5HT1A receptor measured after 15 mins by liquid scintillation counter method | B | 8.64 | pKi | 2.3 | nM | Ki | Bioorg Med Chem (2016) 24: 3994-4007 [PMID:27377863] |
ChEMBL | The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand. | B | 8.68 | pKi | 2.1 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from 5HT1A receptor in rat hippocampal membranes after 20 mins | B | 8.68 | pKi | 2.1 | nM | Ki | Eur J Med Chem (2013) 63: 484-500 [PMID:23524160] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain. | B | 8.7 | pKi | 2 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | Binding affinity to 5HT1A receptor in rat cortex membrane | B | 8.73 | pKi | 1.86 | nM | Ki | J Med Chem (2007) 50: 5024-5033 [PMID:17803293] |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 1A receptor | B | 8.77 | pKi | 1.7 | nM | Ki | J Med Chem (1988) 31: 867-870 [PMID:2965244] |
ChEMBL | Displacement of [3H]8-OHDPAT from 5HT1A receptor in rat hippocampus | B | 8.8 | pKi | 1.6 | nM | Ki | J Med Chem (2009) 52: 6946-6950 [PMID:19831400] |
ChEMBL | Displacement of [3H]8-OHDPAT from 5HT1A receptor in rat hippocampus | B | 8.8 | pKi | 1.6 | nM | Ki | J Med Chem (2009) 52: 3548-3562 [PMID:19425598] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand. | B | 8.8 | pKi | 1.58 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor | B | 8.28 | pIC50 | 5.2 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor | B | 8.28 | pIC50 | 5.2 | nM | IC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
ChEMBL | Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand | B | 8.28 | pIC50 | 5.2 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
ChEMBL | In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane. | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1997) 40: 574-585 [PMID:9046348] |
ChEMBL | Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor | B | 8.59 | pIC50 | 2.6 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Agonist activity at 5HT1A receptor in CRL:CD(SD)BR-COBS rat hippocampus assessed as increase in [35S]GTPgammaS binding | F | 6.49 | pEC50 | 323 | nM | EC50 | J Med Chem (2008) 51: 4529-4538 [PMID:18598015] |
ChEMBL | Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor | F | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1898] [GtoPdb: 2] [UniProtKB: P28222] | ||||||||
GtoPdb | - | - | 8.4 | pKd | - | - | - |
Proc Natl Acad Sci USA (1992) 89: 3630-4 [PMID:1565658]; J Neurochem (1996) 67: 2096-103 [PMID:8863519] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT1B receptor | B | 7.74 | pKi | 18 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [125I]CYP from human 5HT1B receptor | B | 7.85 | pKi | 14 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta | B | 8.15 | pKi | 7.1 | nM | Ki | J Med Chem (1995) 38: 3602-3607 [PMID:7658447] |
ChEMBL | Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells | F | 8.17 | pKi | 6.76 | nM | Ki | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand | B | 8.17 | pKi | 6.76 | nM | Ki | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
ChEMBL | Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand | B | 8.3 | pKi | 5.01 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor | B | 8.32 | pKi | 4.8 | nM | Ki | J Med Chem (2003) 46: 265-283 [PMID:12519065] |
ChEMBL | Binding affinity to human 5-HT1B receptor by radioligand displacement assay | B | 8.4 | pKi | 4 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (1996) 39: 314-322 [PMID:8568822] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1B receptor expressed in CHOK1 cells by liquid scintillation counting | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (2008) 51: 3609-3616 [PMID:18507369] |
GtoPdb | - | - | 9 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 447-53 [PMID:10431754]; Proc Natl Acad Sci USA (1992) 89: 3630-4 [PMID:1565658]; Br J Pharmacol (1997) 121: 737-42 [PMID:9208142]; Br J Pharmacol (1998) 125: 202-8 [PMID:9776361]; Mol Pharmacol (2000) 58: 1042-9 [PMID:11040052]; Eur J Pharmacol (1996) 314: 365-72 [PMID:8957260] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT1B receptor | B | 7.54 | pIC50 | 29 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Inhibition of 5HT1B receptor | B | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Binding affinity to 5-HT1B receptor (unknown origin) by radioligand displacement assay | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Binding affinity to human 5-HT1B receptor by radioligand displacement assay | B | 8.19 | pIC50 | 6.5 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1B receptor | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus | B | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells | F | 8.32 | pEC50 | 4.82 | nM | EC50 | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist | F | 8.33 | pEC50 | 4.67 | nM | EC50 | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
5-HT1B receptor in Mouse [GtoPdb: 2] [UniProtKB: P28334] | ||||||||
GtoPdb | - | - | 8.1 | pKi | - | - | - | Proc Natl Acad Sci USA (1992) 89: 3020-4 [PMID:1557407] |
5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3459] [GtoPdb: 2] [UniProtKB: P28564] | ||||||||
ChEMBL | Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand. | B | 7.6 | pKi | 25 | nM | Ki | J Med Chem (1987) 30: 1-12 [PMID:3543362] |
ChEMBL | Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor | B | 8.27 | pKi | 5.4 | nM | Ki | J Med Chem (1988) 31: 867-870 [PMID:2965244] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT | B | 8.27 | pKi | 5.4 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain. | B | 8.3 | pKi | 5 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate | B | 8.46 | pKi | 3.47 | nM | Ki | J Med Chem (1988) 31: 1406-1412 [PMID:3385733] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand. | B | 8.6 | pKi | 2.51 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand. | B | 8.6 | pKi | 2.5 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum. | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
ChEMBL | Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand. | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Displacement of [125I]CYP from rat cerebral cortex 5-HT1B receptor in the presence of isoproternol | B | 8.31 | pIC50 | 4.9 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [125I]CYP from rat cerebral cortex 5HT1B receptor measured after 120 mins by scintillation counting method | B | 8.31 | pIC50 | 4.9 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor | B | 8.34 | pIC50 | 4.6 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra | B | 7.59 | pEC50 | 26 | nM | EC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
5-HT1D receptor/Serotonin 1d (5-HT1d) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1983] [GtoPdb: 3] [UniProtKB: P28221] | ||||||||
ChEMBL | Binding affinity for 5-hydroxytryptamine 1D receptor was determined | B | 7.9 | pKd | 7.9 | - | pKD | J Med Chem (1993) 36: 1918-1919 [PMID:8515429] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT | B | 8.26 | pKi | 5.5 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand | B | 8.3 | pKi | 5.06 | nM | Ki | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
ChEMBL | Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells | F | 8.3 | pKi | 5.06 | nM | Ki | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha | B | 8.32 | pKi | 4.8 | nM | Ki | J Med Chem (1995) 38: 3602-3607 [PMID:7658447] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate | B | 8.52 | pKi | 3 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor | B | 8.7 | pKi | 2 | nM | Ki | J Med Chem (1999) 42: 526-531 [PMID:9986723] |
ChEMBL | In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement. | B | 8.77 | pKi | 1.7 | nM | Ki | J Med Chem (1996) 39: 314-322 [PMID:8568822] |
GtoPdb | - | - | 9 | pKi | - | - | - |
Proc Natl Acad Sci USA (1992) 89: 3630-4 [PMID:1565658]; Br J Pharmacol (1997) 121: 737-42 [PMID:9208142]; Br J Pharmacol (1998) 125: 202-8 [PMID:9776361]; Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 447-53 [PMID:10431754]; Mol Pharmacol (1996) 50: 1567-80 [PMID:8967979]; Eur J Pharmacol (1996) 314: 365-72 [PMID:8957260]; Mol Pharmacol (1991) 40: 143-8 [PMID:1652050] |
ChEMBL | Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1D receptor expressed in CHOK1 cells by liquid scintillation counting | B | 9.3 | pKi | 0.5 | nM | Ki | J Med Chem (2008) 51: 3609-3616 [PMID:18507369] |
ChEMBL | Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand | B | 8.52 | pIC50 | 3 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
Serotonin 1d (5-HT1d) receptor in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105] [UniProtKB: P79400] | ||||||||
ChEMBL | Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (1995) 38: 1799-1810 [PMID:7752204] |
ChEMBL | Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (1993) 36: 1529-1538 [PMID:8496922] |
ChEMBL | Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (1993) 3: 993-997 |
5-HT1D receptor/Serotonin 1d (5-HT1d) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5450] [GtoPdb: 3] [UniProtKB: P28565] | ||||||||
ChEMBL | Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
ChEMBL | Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor | F | 8.28 | pEC50 | 5.2 | nM | EC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
Serotonin 1d (5-HT1d) receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2304407] [UniProtKB: Q60484] | ||||||||
ChEMBL | Binding affinity against 5-hydroxytryptamine 1D receptor | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra | B | 7.8 | pEC50 | 16 | nM | EC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra | B | 8.07 | pEC50 | 8.5 | nM | EC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
ChEMBL | Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra. | F | 8.28 | pEC50 | 5.2 | nM | EC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
5-ht1e receptor/Serotonin 1e (5-HT1e) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2182] [GtoPdb: 4] [UniProtKB: P28566] | ||||||||
ChEMBL | Displacement of [3H]5HT from 5-HT1E receptor (unknown origin) | B | 7.96 | pKi | 11 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 576-579 [PMID:24365159] |
ChEMBL | Displacement of [3H]5HT from 5-HT1E receptor (unknown origin) | B | 7.97 | pKi | 10.72 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 576-579 [PMID:24365159] |
GtoPdb | - | - | 8.2 | pKi | - | - | - |
Proc Natl Acad Sci USA (1992) 89: 5517-21 [PMID:1608964]; Proc Natl Acad Sci USA (1993) 90: 408-12 [PMID:8380639]; Eur J Pharmacol (2004) 484: 127-39 [PMID:14744596]; Bioorg Med Chem (2004) 12: 2545-52 [PMID:15110837] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
5-HT1F receptor/Serotonin 1f (5-HT1f) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1805] [GtoPdb: 5] [UniProtKB: P30939] | ||||||||
GtoPdb | - | - | 8 | pKd | - | - | - | Proc Natl Acad Sci USA (1993) 90: 408-12 [PMID:8380639] |
GtoPdb | - | - | 8 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2005) 371: 169-77 [PMID:15900510]; Proc Natl Acad Sci USA (1993) 90: 408-12 [PMID:8380639]; Neuropharmacology (1997) 36: 569-76 [PMID:9225282] |
ChEMBL | In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor | F | 8.1 | pEC50 | 7.9 | nM | EC50 | J Med Chem (2001) 44: 4031-4034 [PMID:11708905] |
5-HT1F receptor in Rat [GtoPdb: 5] [UniProtKB: P30940] | ||||||||
GtoPdb | - | - | 7.2 | pIC50 | - | - | - | Proc Natl Acad Sci USA (1993) 90: 2184-8 [PMID:8384716] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
GtoPdb | - | - | 8.9 | pKd | - | - | - | Biochem Pharmacol (1996) 51: 71-6 [PMID:8534270] |
ChEMBL | Displacement of [N-methyl-3H]LSD from human 5HT2A receptor expressed in HEK293 cells | B | 6.16 | pKi | 690 | nM | Ki | J Nat Prod (2006) 69: 1421-1424 [PMID:17067154] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin | B | 6.29 | pKi | 510 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand | B | 6.4 | pKi | 398.11 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 6.49 | pKi | 323.59 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Displacement of [3H]methylspiperone form human cloned 5HT2A receptor expressed in african green monkey COS7 cells by scintillation spectroscopy | B | 6.49 | pKi | 320 | nM | Ki | J Nat Prod (2002) 65: 476-480 [PMID:11975483] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 6.49 | pKi | 320 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Displacement of [3H]INBMeO from human 5HT2A receptor expressed in human A549 cells | B | 6.8 | pKi | 160 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]INBMeO from human 5HT2A receptor expressed in human HEK293 cells | B | 6.82 | pKi | 150 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in human HEK293 cells | B | 6.89 | pKi | 130 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in human A549 cells | B | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT2A receptor expressed in HEK cells by radioligand completion assay relative to control | B | 7.76 | pKi | 17.2 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
ChEMBL | Displacement of [125I]DOI from human 5HT2A | B | 7.85 | pKi | 14 | nM | Ki | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line | B | 7.85 | pKi | 14 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Displacement of [125I]DOI from human 5HT2A receptor expressed in HEK293 cell membranes | B | 7.94 | pKi | 11.5 | nM | Ki | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
ChEMBL | Displacement of [125I]DOI from cloned human 5HT2A receptor expressed in CHO cells | B | 8.09 | pKi | 8.2 | nM | Ki | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand | B | 8.09 | pKi | 8.2 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
GtoPdb | - | - | 8.4 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]; Biochem Pharmacol (1996) 51: 71-6 [PMID:8534270]; J Med Chem (2003) 46: 4188-95 [PMID:12954071]; Mol Pharmacol (1990) 38: 604-9 [PMID:2233697]; Mol Pharmacol (1994) 45: 277-86 [PMID:8114677]; J Biol Chem (1996) 271: 14672-5 [PMID:8663249] |
ChEMBL | Antagonist activity at recombinant human 5-HT2A expressed in human U2OS cells by pathhunter beta-arrestin assay | B | 7.55 | pIC50 | 27.9 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127358-127358 [PMID:32631554] |
ChEMBL | Partial agonist activity at human 5-HT2A receptor expressed in HEK293 cells preincubated for 1 hr at 37 degC followed by incubated for 15 mins at room temperature by IP-One assay | B | 6.52 | pEC50 | 302 | nM | EC50 | Bioorg Med Chem (2015) 23: 3933-3937 [PMID:25583099] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 6.82 | pEC50 | 150 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 6.83 | pEC50 | 147.91 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation | F | 6.9 | pEC50 | 125.89 | nM | EC50 | J Med Chem (2008) 51: 305-313 [PMID:18095642] |
ChEMBL | Agonist activity at human cloned 5HT2A receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis | F | 7.15 | pEC50 | 70 | nM | EC50 | Bioorg Med Chem (2008) 16: 1966-1982 [PMID:18035544] |
ChEMBL | Agonist activity at 5-HT2A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay | B | 7.33 | pEC50 | 47 | nM | EC50 | Eur J Med Chem (2016) 123: 332-353 [PMID:27487565] |
ChEMBL | Agonist activity at 5HT2A receptor (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay | B | 7.73 | pEC50 | 18.62 | nM | EC50 | US-20040213816-A1. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2004) |
ChEMBL | Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay | B | 7.8 | pEC50 | 16 | nM | EC50 | J Med Chem (2013) 56: 4671-4690 [PMID:23675993] |
ChEMBL | Binding to human 5HT2A receptor expressed in CHO cells | B | 7.96 | pEC50 | 11 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader | F | 7.96 | pEC50 | 11 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay | F | 8.12 | pEC50 | 7.6 | nM | EC50 | ACS Med Chem Lett (2011) 2: 929-932 [PMID:22778800] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 8.24 | pEC50 | 5.8 | nM | EC50 | J Med Chem (2009) 52: 1885-1902 [PMID:19284718] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 8.59 | pEC50 | 2.6 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 8.59 | pEC50 | 2.57 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.63 | pEC50 | 2.35 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.63 | pEC50 | 2.34 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 8.73 | pEC50 | 1.88 | nM | EC50 | J Med Chem (2015) 58: 1992-2002 [PMID:25633969] |
ChEMBL | Agonist activity at serotonin 5-HT2A receptor (unknown origin) expressed in HEK293 cells assessed as induction of calcium flux after 60 mins by calcium 4-dye based FLIPR assay | F | 8.8 | pEC50 | 1.6 | nM | EC50 | J Med Chem (2018) 61: 10017-10039 [PMID:30383372] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.81 | pEC50 | 1.55 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.82 | pEC50 | 1.5 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in CHO-K1 cells by calcium 4 dye based FLIPR assay | F | 8.96 | pEC50 | 1.1 | nM | EC50 | Eur J Med Chem (2020) 207: 112709-112709 [PMID:32877805] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.29 | pEC50 | 0.51 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.29 | pEC50 | 0.51 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5377] [GtoPdb: 6] [UniProtKB: P35363] | ||||||||
ChEMBL | Agonist activity at mouse 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.28 | pEC50 | 0.53 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
ChEMBL | Agonist activity at mouse 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.28 | pEC50 | 0.52 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL322] [GtoPdb: 6] [UniProtKB: P14842] | ||||||||
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand. | B | 5.9 | pKi | 1258.93 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Displacement of [3H]ketanserin from 5HT2A receptor in rat cortex | B | 5.9 | pKi | 1258 | nM | Ki | J Med Chem (2009) 52: 3548-3562 [PMID:19425598] |
ChEMBL | Displacement of [3H]ketanserin from 5HT2A receptor in rat cortex | B | 5.9 | pKi | 1258 | nM | Ki | J Med Chem (2009) 52: 6946-6950 [PMID:19831400] |
ChEMBL | Displacement of [3H]ketanserin from 5HT2A in Sprague-Dawley rat frontal cortex membranes measured after 20 mins | B | 6.22 | pKi | 600 | nM | Ki | J Med Chem (2017) 60: 2605-2628 [PMID:28244748] |
GtoPdb | - | - | 6.5 | pKi | - | - | - |
Mol Pharmacol (2000) 58: 877-86 [PMID:11040033]; Circulation (2000) 102: 2836-41 [PMID:11104741]; J Pharmacol Exp Ther (1998) 286: 85-90 [PMID:9655845] |
ChEMBL | Displacement of [3H]DOI-HCL from 5HT2A in Sprague-Dawley rat frontal cortex membranes measured after 20 mins | B | 7.97 | pKi | 10.6 | nM | Ki | J Med Chem (2017) 60: 2605-2628 [PMID:28244748] |
ChEMBL | In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex | B | 9.52 | pKi | 0.3 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Displacement of [3H]-ketanserin from 5HT2A receptor low affinity component in rat brain cortical membranes after 15 mins by competition assay | B | 4.51 | pIC50 | 30600 | nM | IC50 | Eur J Med Chem (2013) 66: 122-134 [PMID:23792350] |
ChEMBL | Displacement of [3H]-ketanserin from 5HT2A receptor in rat brain cortical membranes after 15 mins by competition assay in presence of Gpp(NH)p | B | 4.89 | pIC50 | 13000 | nM | IC50 | Eur J Med Chem (2013) 66: 122-134 [PMID:23792350] |
ChEMBL | Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor | B | 5.63 | pIC50 | 2350 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Displacement of [3H]-ketanserin from 5HT2A receptor high affinity component in rat brain cortical membranes after 15 mins by competition assay | B | 6.22 | pIC50 | 600 | nM | IC50 | Eur J Med Chem (2013) 66: 122-134 [PMID:23792350] |
ChEMBL | Inhibition of [125I]DOI binding to 5HT2A receptor in rat cerebral cortex | B | 9.03 | pIC50 | 0.94 | nM | IC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex | B | 9.05 | pIC50 | 0.9 | nM | IC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells | F | 6.45 | pEC50 | 351 | nM | EC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Activity against 5HT2A mediated intracellular calcium mobilization by FLIPR in rat vascular smooth muscle cells | F | 7.24 | pEC50 | 57.9 | nM | EC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells | F | 7.25 | pEC50 | 55.8 | nM | EC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
ChEMBL | Displacement of [3H]LSD from 5-HT2B receptor (unknown origin) | B | 7.87 | pKi | 13.49 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 1489-1492 [PMID:24582985] |
ChEMBL | Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand | B | 7.89 | pKi | 13 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Displacement of [125I]DOI from cloned human 5HT2B receptor expressed in CHO cells | B | 7.89 | pKi | 13 | nM | Ki | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line | B | 7.92 | pKi | 12 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Displacement of [3H]5-HT from human 5HT2B | B | 7.92 | pKi | 12 | nM | Ki | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT2B receptor expressed in HEK cells by radioligand completion assay relative to control | B | 7.97 | pKi | 10.8 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
GtoPdb | - | - | 8.4 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]; J Med Chem (2003) 46: 4188-95 [PMID:12954071]; Circulation (2000) 102: 2836-41 [PMID:11104741]; Mol Pharmacol (1994) 46: 227-34 [PMID:8078486]; Br J Pharmacol (2004) 143: 549-60 [PMID:15466450] |
ChEMBL | Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation | F | 7.6 | pEC50 | 25.12 | nM | EC50 | J Med Chem (2008) 51: 305-313 [PMID:18095642] |
ChEMBL | Agonist activity at human recombinant 5HT2B receptor assessed as induction of calcium mobilization by FLIPR assay | F | 7.96 | pEC50 | 11 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 4999-5003 [PMID:19646865] |
ChEMBL | Agonist activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as myo-[3H]inositol hydrolysis | F | 8.24 | pEC50 | 5.8 | nM | EC50 | Bioorg Med Chem (2008) 16: 1966-1982 [PMID:18035544] |
ChEMBL | Agonist activity at human 5-HT2BR expressed in CHO cells assessed as induction of IP1 accumulation after 30 mins by HTRF method | F | 8.35 | pEC50 | 4.5 | nM | EC50 | Eur J Med Chem (2018) 145: 790-804 [PMID:29407591] |
ChEMBL | Binding to human 5HT2B receptor expressed in CHO cells | B | 8.82 | pEC50 | 1.5 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader | F | 8.82 | pEC50 | 1.5 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.84 | pEC50 | 1.46 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.84 | pEC50 | 1.45 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.96 | pEC50 | 1.1 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.97 | pEC50 | 1.07 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 9.04 | pEC50 | 0.92 | nM | EC50 | J Med Chem (2015) 58: 1992-2002 [PMID:25633969] |
ChEMBL | Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay | F | 9.07 | pEC50 | 0.86 | nM | EC50 | ACS Med Chem Lett (2011) 2: 929-932 [PMID:22778800] |
ChEMBL | Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2009) 52: 1885-1902 [PMID:19284718] |
ChEMBL | Agonist activity at 5-HT2B receptor (unknown origin) by calcium mobilization assay | F | 10.15 | pEC50 | 0.07 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127511-127511 [PMID:32853682] |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL323] [GtoPdb: 7] [UniProtKB: P30994] | ||||||||
GtoPdb | - | - | 8 | pKi | - | - | - | Mol Pharmacol (1993) 43: 419-26 [PMID:8450835] |
ChEMBL | Agonist activity at 5HT2b receptor in Wistar rat fundus measured for 90 secs | B | 8.38 | pEC50 | 4.19 | nM | EC50 | Eur J Med Chem (2015) 103: 289-301 [PMID:26363507] |
ChEMBL | Activity against 5HT2B receptor in longitudinal stomach fundus strips in wistar rats | F | 8.46 | pEC50 | 3.5 | nM | EC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes using 11 concentration of ligand after 90 mins by scintillation counting using complete competition binding curves analysis | B | 6.35 | pKi | 445 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 2560-2564 [PMID:22381048] |
ChEMBL | Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes after 90 mins by scintillation counting | B | 6.67 | pKi | 214 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 2560-2564 [PMID:22381048] |
ChEMBL | Displacement of [3H]mesulergine form human cloned 5HT2C receptor expressed in african green monkey COS7 cells by scintillation spectroscopy | B | 6.89 | pKi | 130 | nM | Ki | J Nat Prod (2002) 65: 476-480 [PMID:11975483] |
ChEMBL | Displacement of [3H]mesulergine from human 5HT2C receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 7.1 | pKi | 79.43 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Displacement of [3H]mesulergine from human 5HT2C receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 7.1 | pKi | 79 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand | B | 7.3 | pKi | 50.12 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand. | B | 7.46 | pKi | 35 | nM | Ki | J Med Chem (1987) 30: 1-12 [PMID:3543362] |
ChEMBL | Displacement of [N-methyl-3H]LSD from human 5HT2C receptor expressed in HEK293 cells | B | 7.7 | pKi | 20 | nM | Ki | J Nat Prod (2006) 69: 1421-1424 [PMID:17067154] |
ChEMBL | Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand | B | 8.08 | pKi | 8.3 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Displacement of [125I]DOI from cloned human 5HT2C receptor expressed in CHO cells | B | 8.08 | pKi | 8.3 | nM | Ki | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line | B | 8.16 | pKi | 6.9 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Displacement of [3H]5-HT from human 5HT2C | B | 8.16 | pKi | 6.9 | nM | Ki | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
GtoPdb | - | - | 8.6 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]; J Med Chem (2003) 46: 4188-95 [PMID:12954071]; J Neurochem (1999) 72: 2127-34 [PMID:10217294]; Synapse (2000) 35: 144-150 [PMID:10611640]; Eur J Pharmacol (2004) 483: 37-43 [PMID:14709324] |
ChEMBL | inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand | B | 7.09 | pIC50 | 81 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Antagonist activity at recombinant human 5-HT2C expressed in human U2OS cells by pathhunter beta-arrestin assay | B | 8.9 | pIC50 | 1.25 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127358-127358 [PMID:32631554] |
ChEMBL | Partial agonist activity at human 5-HT2C receptor expressed in HEK293 cells preincubated for 1 hr at 37 degC followed by incubated for 15 mins at room temperature by IP-One assay | B | 6.72 | pEC50 | 190.55 | nM | EC50 | Bioorg Med Chem (2015) 23: 3933-3937 [PMID:25583099] |
ChEMBL | Agonist activity at 5HT2C receptor VGV isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay | B | 7.29 | pEC50 | 51.29 | nM | EC50 | US-20040213816-A1. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2004) |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 7.36 | pEC50 | 44 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 7.36 | pEC50 | 43.65 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation | F | 7.6 | pEC50 | 25.12 | nM | EC50 | J Med Chem (2008) 51: 305-313 [PMID:18095642] |
ChEMBL | Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay | F | 7.6 | pEC50 | 25 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 4999-5003 [PMID:19646865] |
ChEMBL | Agonist activity at human cloned 5HT2C receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis | F | 7.62 | pEC50 | 24 | nM | EC50 | Bioorg Med Chem (2008) 16: 1966-1982 [PMID:18035544] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human HEK293 cells assessed as induction of beta-arrestin-2 recruitment incubated for 20 hrs by Tango assay | B | 7.66 | pEC50 | 21.88 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human HEK293 cells assessed as induction of beta-arrestin-2 recruitment incubated for 20 hrs by Tango assay | B | 7.68 | pEC50 | 21 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at tTA containing TEV cleavage site-fused 5-HT2C-INI receptor isoform (unknown origin) expressed in TEV-fused beta-arrestin2 expressing HEK cells assessed as induction of beta-arrestin2 recruitment after 20 hrs by Tango assay | B | 7.82 | pEC50 | 15.14 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Agonist activity at tTA containing TEV cleavage site-fused 5-HT2C-INI receptor isoform (unknown origin) expressed in TEV-fused beta-arrestin2 expressing HEK cells assessed as induction of beta-arrestin2 recruitment after 20 hrs by Tango assay | B | 7.82 | pEC50 | 15 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader | F | 8.77 | pEC50 | 1.7 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Binding to human 5HT2C receptor expressed in CHO cells | B | 8.77 | pEC50 | 1.7 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assay | F | 8.79 | pEC50 | 1.63 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 2560-2564 [PMID:22381048] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 9.06 | pEC50 | 0.87 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 9.06 | pEC50 | 0.87 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor stably expressed in HEK293 cells co-expressing Gq assessed as induction of calcium mobilization measured at 1 sec interval for 60 secs by Fluo-4 calcium dye based FLIPR assay | F | 9.39 | pEC50 | 0.41 | nM | EC50 | J Med Chem (2020) 63: 4579-4602 [PMID:32282200] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 9.4 | pEC50 | 0.4 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 9.46 | pEC50 | 0.35 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 9.68 | pEC50 | 0.21 | nM | EC50 | J Med Chem (2015) 58: 1992-2002 [PMID:25633969] |
ChEMBL | Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay | F | 9.72 | pEC50 | 0.19 | nM | EC50 | Eur J Med Chem (2019) 182: 111626-111626 [PMID:31445232] |
ChEMBL | Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay | F | 9.72 | pEC50 | 0.19 | nM | EC50 | Eur J Med Chem (2019) 182: 111626-111626 [PMID:31445232] |
ChEMBL | Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay | F | 9.74 | pEC50 | 0.18 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay | F | 9.77 | pEC50 | 0.17 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.77 | pEC50 | 0.17 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.78 | pEC50 | 0.17 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.85 | pEC50 | 0.14 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.87 | pEC50 | 0.13 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay | F | 10.05 | pEC50 | 0.09 | nM | EC50 | ACS Med Chem Lett (2011) 2: 929-932 [PMID:22778800] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 10.05 | pEC50 | 0.09 | nM | EC50 | J Med Chem (2009) 52: 1885-1902 [PMID:19284718] |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL324] [GtoPdb: 8] [UniProtKB: P08909] | ||||||||
ChEMBL | Binding affinity for 5-hydroxytryptamine 1C receptor was determined | B | 7.5 | pKd | 7.5 | - | pKD | J Med Chem (1993) 36: 1918-1919 [PMID:8515429] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand. | B | 7.5 | pKi | 31.62 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine | B | 7.64 | pKi | 23 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
GtoPdb | - | - | 7.9 | pKi | - | - | - |
Circulation (2000) 102: 2836-41 [PMID:11104741]; J Neurochem (1997) 69: 1138-44 [PMID:9282936] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain. | B | 8 | pKi | 10 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1C receptor | B | 7.09 | pIC50 | 81 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor | B | 7.38 | pIC50 | 42 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Activity against recombinant rat 5HT2C mediated intracellular calcium mobilization by FLIPR in SR3T3 cells | F | 8.55 | pEC50 | 2.8 | nM | EC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
5-HT3E/5-HT3B/5-HT3A/5-HT3D/5-HT3C/Serotonin 3 (5-HT3) receptor in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2094132] [GtoPdb: 377, 374, 373, 376, 375] [UniProtKB: A5X5Y0, O95264, P46098, Q70Z44, Q8WXA8] | ||||||||
ChEMBL | Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694. | B | 6.84 | pKi | 144.54 | nM | Ki | Bioorg Med Chem Lett (1993) 3: 205-208 |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 3 receptor | B | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem Lett (2002) 12: 2743-2747 [PMID:12217367] |
5-HT3A/5-HT3B/Serotonin 3 (5-HT3) receptor in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094116] [GtoPdb: 373, 374] [UniProtKB: P35563, Q9JJ16] | ||||||||
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand. | B | 6.4 | pKi | 398.11 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices | B | 6.41 | pKi | 390 | nM | Ki | J Med Chem (1992) 35: 1486-1489 [PMID:1573641] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630 | B | 6.49 | pKi | 320 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
ChEMBL | Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement. | B | 7.06 | pKi | 87 | nM | Ki | Bioorg Med Chem Lett (1996) 6: 263-266 |
ChEMBL | Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand | B | 7.18 | pKi | 66 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate. | B | 6.14 | pIC50 | 727 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1899] [GtoPdb: 373] [UniProtKB: P46098] | ||||||||
ChEMBL | Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay | F | 6.3 | pEC50 | 500 | nM | EC50 | J Med Chem (2007) 50: 4616-4629 [PMID:17722904] |
ChEMBL | Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay | F | 6.34 | pEC50 | 457.09 | nM | EC50 | J Med Chem (2007) 50: 4616-4629 [PMID:17722904] |
ChEMBL | Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response | F | 6.75 | pEC50 | 178 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 58-61 [PMID:21146988] |
ChEMBL | Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release | F | 6.85 | pEC50 | 141 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 58-61 [PMID:21146988] |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4972] [GtoPdb: 373] [UniProtKB: P23979] | ||||||||
ChEMBL | Agonist activity at mouse 5HT3A I187A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.05 | pEC50 | 90000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Y143F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.2 | pEC50 | 63000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A W183F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.29 | pEC50 | 51000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A Y153F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.31 | pEC50 | 49000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Y153A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.38 | pEC50 | 42000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A L184V receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.43 | pEC50 | 37000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A I187A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.57 | pEC50 | 27000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A T181A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.62 | pEC50 | 24000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A H185F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.68 | pEC50 | 20900 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A H185Y receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.76 | pEC50 | 17200 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Y153F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.82 | pEC50 | 15000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A L184V receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.96 | pEC50 | 11000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A T186A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.02 | pEC50 | 9600 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A T181A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.15 | pEC50 | 7100 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A H185F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.21 | pEC50 | 6200 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A H185Y receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.29 | pEC50 | 5100 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A Q188A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.36 | pEC50 | 4400 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A I190V receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.36 | pEC50 | 4400 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at wild type mouse 5HT3A receptor expressed in Xenopus oocyte by two-electrode voltage patch clamp method | F | 5.47 | pEC50 | 3400 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A S182A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.48 | pEC50 | 3300 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A T186A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.54 | pEC50 | 2900 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A I190V receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.88 | pEC50 | 1320 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Q188A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.89 | pEC50 | 1300 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A S182A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 6.01 | pEC50 | 980 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2411] [GtoPdb: 373] [UniProtKB: P35563] | ||||||||
ChEMBL | Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes | F | 4.92 | pEC50 | 12000 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 1849-1853 [PMID:15050614] |
5-HT4 receptor/Serotonin 4 (5-HT4) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1875] [GtoPdb: 9] [UniProtKB: Q13639] | ||||||||
GtoPdb | - | - | 8.8 | pKd | - | - | - | J Neurochem (2000) 74: 478-89 [PMID:10646498] |
ChEMBL | Displacement of [3H]GR-113808 from human 5HT4 isoform E receptor expressed in rat C6 cells by liquid scintillation counting | B | 5.98 | pKi | 1049 | nM | Ki | J Med Chem (2009) 52: 2214-2225 [PMID:19334715] |
ChEMBL | Displacement of [N-methyl-3H]GR-113808 from human 5HT4 receptor expressed in HEK293 cells | B | 6.3 | pKi | 500 | nM | Ki | J Nat Prod (2006) 69: 1421-1424 [PMID:17067154] |
ChEMBL | Binding affinity to recombinant human brain 5HT4 receptor by radio ligand binding assay | B | 6.61 | pKi | 246 | nM | Ki | Eur J Med Chem (2019) 182: 111596-111596 [PMID:31419776] |
ChEMBL | Displacement of [3H]GR-113808 from human recombinant 5HT4b receptor expressed in HEK293 cells by scintillation counting | B | 6.96 | pKi | 109.65 | nM | Ki | Eur J Med Chem (2009) 44: 2952-2959 [PMID:19223092] |
GtoPdb | - | - | 7 | pKi | - | - | - |
J Neurochem (1998) 70: 2252-61 [PMID:9603189]; Neuroreport (1997) 8: 3189-96 [PMID:9351641]; J Neurochem (1997) 69: 1810-9 [PMID:9349523]; J Neurochem (2000) 74: 478-89 [PMID:10646498]; Br J Pharmacol (2000) 129: 771-81 [PMID:10683202]; Br J Pharmacol (2000) 131: 827-35 [PMID:11030734]; Br J Pharmacol (2000) 130: 527-38 [PMID:10821780]; Br J Pharmacol (2004) 143: 549-60 [PMID:15466450]; Br J Pharmacol (2004) 143: 361-70 [PMID:15351779]; Naunyn Schmiedebergs Arch Pharmacol (2001) 363: 146-60 [PMID:11218067] |
ChEMBL | Displacement of [3H]GR-113808 from human 5HT4b receptor expressed in COS7 cell membrane by scintillation counting | B | 7.53 | pKi | 29.51 | nM | Ki | Eur J Med Chem (2009) 44: 2952-2959 [PMID:19223092] |
ChEMBL | Displacement of [3H]-GR 113808 from recombinant human brain 5HT4 receptor measured after 60 mins by radio ligand binding assay | B | 6.49 | pIC50 | 323 | nM | IC50 | Eur J Med Chem (2019) 182: 111596-111596 [PMID:31419776] |
ChEMBL | Activity at SER4 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay | F | 7 | pEC50 | 100 | nM | EC50 | Nature (2007) 450: 553-556 [PMID:18033297] |
ChEMBL | Agonist activity at human 5HT4 isoform E receptor expressed in rat C6 cells assessed as cAMP accumulation by radio-immunoassay relative to 5HT | F | 7.92 | pEC50 | 12 | nM | EC50 | J Med Chem (2009) 52: 2214-2225 [PMID:19334715] |
5-HT4 receptor in Mouse [GtoPdb: 9] [UniProtKB: P97288] | ||||||||
GtoPdb | - | - | 7.2 | pKi | - | - | - | FEBS Lett (1996) 398: 19-25 [PMID:8946946] |
5-HT4 receptor/Serotonin 4 (5-HT4) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4317] [GtoPdb: 9] [UniProtKB: Q62758] | ||||||||
GtoPdb | - | - | 7.7 | pKd | - | - | - | Eur J Pharmacol (1996) 304: 231-5 [PMID:8813606] |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand | B | 6.73 | pKi | 187 | nM | Ki | J Med Chem (1997) 40: 608-621 [PMID:9046352] |
ChEMBL | Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement. | B | 7.43 | pKi | 37.4 | nM | Ki | Bioorg Med Chem Lett (1996) 6: 263-266 |
GtoPdb | - | - | 8.2 | pKi | - | - | - |
EMBO J (1995) 14: 2806-15 [PMID:7796807]; Eur J Pharmacol (1996) 304: 231-5 [PMID:8813606]; Neuropharmacology (1997) 36: 671-9 [PMID:9225293] |
ChEMBL | Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor | B | 6.83 | pIC50 | 147 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae | F | 8.43 | pIC50 | 3.7 | nM | IC50 | Bioorg Med Chem Lett (1994) 4: 1433-1436 |
ChEMBL | In vitro relaxation of carbachol pre-contracted rat oesophageal TMM. | F | 7.77 | pEC50 | 17.1 | nM | EC50 | Bioorg Med Chem Lett (1996) 6: 263-266 |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae | F | 8.2 | pEC50 | 6.31 | nM | EC50 | Bioorg Med Chem Lett (1993) 3: 1375-1378 |
Serotonin 4 (5-HT4) receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5017] [UniProtKB: O70528] | ||||||||
ChEMBL | The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand. | B | 6.64 | pKi | 230 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand. | B | 7 | pKi | 100 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Displacement of [3H]GR-113808 from 5HT4 receptor in guinea pig striatum | B | 7 | pKi | 100 | nM | Ki | J Med Chem (2009) 52: 3548-3562 [PMID:19425598] |
ChEMBL | Displacement of [3H]GR-113808 from 5HT4 receptor in guinea pig striatum | B | 7 | pKi | 100 | nM | Ki | J Med Chem (2009) 52: 6946-6950 [PMID:19831400] |
ChEMBL | Agonist activity at 5HT4 receptor in guinea pig colon assessed as longitudinal muscle plexus contraction | F | 8 | pEC50 | 10 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 4849-4853 [PMID:22683222] |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum | F | 8.3 | pEC50 | 5 | nM | EC50 | J Med Chem (1997) 40: 608-621 [PMID:9046352] |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum | F | 8.3 | pEC50 | 5 | nM | EC50 | Bioorg Med Chem Lett (1994) 4: 1433-1436 |
5-HT5A receptor/Serotonin 5a (5-HT5a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3426] [GtoPdb: 10] [UniProtKB: P47898] | ||||||||
ChEMBL | Binding affinity for rodent 5-hydroxytryptamine 5A receptor | B | 6.6 | pKi | 250 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]LSD from human 5HT5A receptor | B | 6.77 | pKi | 170 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting | B | 6.89 | pKi | 130 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand | B | 6.9 | pKi | 126 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
GtoPdb | - | - | 6.9 | pKi | - | - | - |
FEBS Lett (1994) 355: 242-6 [PMID:7988681]; Eur J Pharmacol (2001) 418: 157-67 [PMID:11343685] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT5A receptor | B | 6.96 | pKi | 110 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Binding affinity to human 5-HT5a receptor by radioligand displacement assay | B | 7.09 | pKi | 82 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Binding affinity to human 5-HT5A receptor by radioligand displacement assay | B | 6.55 | pIC50 | 280 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting | B | 6.59 | pIC50 | 260 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Inhibition of human 5HT5A receptor | B | 6.74 | pIC50 | 184 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method | B | 6.74 | pIC50 | 180 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT5A receptor | B | 6.74 | pIC50 | 180 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT5A receptor expressed in HEK293 cells | B | 6.74 | pIC50 | 180 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Binding affinity to human 5-HT5a receptor by radioligand displacement assay | B | 6.8 | pIC50 | 160 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Percent inhibition against 5-hydroxytryptamine 5A receptor at 1 uM | B | 7.1 | pIC50 | 79 | nM | IC50 | J Med Chem (2005) 48: 6887-6896 [PMID:16250647] |
5-HT5A receptor/Serotonin 5a (5-HT5a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3597] [GtoPdb: 10] [UniProtKB: P30966] | ||||||||
GtoPdb | - | - | 6.6 | pKi | - | - | - |
Mol Pharmacol (1993) 43: 313-9 [PMID:8450829]; Eur J Pharmacol (2001) 418: 157-67 [PMID:11343685]; FEBS Lett (1995) 377: 451-6 [PMID:8549774] |
ChEMBL | Binding affinity towards mouse 5-hydroxytryptamine 5A receptor | B | 6.82 | pKi | 150 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
5-HT5A receptor in Rat [GtoPdb: 10] [UniProtKB: P35364] | ||||||||
GtoPdb | - | - | 6.6 | pKi | - | - | - | Proc Natl Acad Sci USA (1993) 90: 3452-6 [PMID:7682702] |
5-HT6 receptor/Serotonin 6 (5-HT6) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3371] [GtoPdb: 11] [UniProtKB: P50406] | ||||||||
ChEMBL | Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand | B | 6.9 | pKi | 125.89 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Binding affinity to 5-Ht6 receptor (unknown origin) | B | 7 | pKi | 100 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 2333-2338 [PMID:26996373] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 6 receptor | B | 7 | pKi | 100 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 4569-4573 [PMID:15357994] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT6 receptor | B | 7.03 | pKi | 93 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [3H]LSD from human 5HT6 receptor | B | 7.08 | pKi | 84 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand | B | 7.11 | pKi | 78 | nM | Ki | Bioorg Med Chem Lett (2000) 10: 2295-2299 [PMID:11055342] |
ChEMBL | Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand | B | 7.12 | pKi | 75 | nM | Ki | J Med Chem (2000) 43: 1011-1018 [PMID:10715164] |
ChEMBL | Binding affinity to Homo sapiens (human) 5-HT6 receptor | B | 7.15 | pKi | 70 | nM | Ki | Med Chem Res (2005) 14: 1-18 |
ChEMBL | Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand | B | 7.19 | pKi | 65 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 7.21 | pKi | 61 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Binding affinity to human 5-HT6 receptor by radioligand displacement assay | B | 7.3 | pKi | 50 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells | B | 7.48 | pKi | 33 | nM | Ki | J Med Chem (2014) 57: 4543-4557 [PMID:24805037] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in HEK-293 cells incubated for 60 mins by scintillation counting method | B | 7.48 | pKi | 33 | nM | Ki | Eur J Med Chem (2015) 92: 221-235 [PMID:25557493] |
GtoPdb | - | - | 7.5 | pKi | - | - | - |
J Neurochem (1996) 66: 47-56 [PMID:8522988]; Mol Pharmacol (1998) 54: 577-583 [PMID:9730917]; Mol Pharmacol (1997) 52: 515-523 [PMID:9284367] |
ChEMBL | Inhibition of human 5HT6 receptor | B | 6.58 | pIC50 | 262 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT6 receptor | B | 6.7 | pIC50 | 200 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Binding affinity to human 5-HT6 receptor by radioligand displacement assay | B | 6.74 | pIC50 | 180 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 6.89 | pIC50 | 130 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells | B | 6.92 | pIC50 | 120 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method | B | 6.92 | pIC50 | 120 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Binding affinity to human 5-HT6 receptor by radioligand displacement assay | B | 7 | pIC50 | 100 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human 5HT6 receptor by scintillation counting | B | 7.56 | pIC50 | 27.5 | nM | IC50 | J Med Chem (2010) 53: 2521-2527 [PMID:20170099] |
ChEMBL | Agonist activity at serotonin 5-HT6R receptor (unknown origin) expressed in HEK293 cells assessed as induction of calcium flux after 60 mins by calcium 4-dye based FLIPR assay | F | 7.36 | pEC50 | 43.6 | nM | EC50 | J Med Chem (2018) 61: 10017-10039 [PMID:30383372] |
ChEMBL | Agonist activity at human 5HT6 receptor expressed in CHO-K1 cells by calcium 4 dye based FLIPR assay | F | 7.38 | pEC50 | 42.1 | nM | EC50 | Eur J Med Chem (2020) 207: 112709-112709 [PMID:32877805] |
5-HT6 receptor in Rat [GtoPdb: 11] [UniProtKB: P31388] | ||||||||
GtoPdb | - | - | 7.9 | pKd | - | - | - | Neuropharmacology (1997) 36: 713-20 [PMID:9225298] |
GtoPdb | - | - | 7.9 | pKi | - | - | - |
Mol Pharmacol (1993) 43: 320-7 [PMID:7680751]; Neuropharmacology (1997) 36: 713-20 [PMID:9225298]; J Neurochem (1998) 71: 2169-77 [PMID:9798944]; Mol Pharmacol (1998) 54: 577-583 [PMID:9730917] |
5-HT7 receptor/Serotonin 7 (5-HT7) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3155] [GtoPdb: 12] [UniProtKB: P34969] | ||||||||
ChEMBL | Displacement of [3H]5-HT from human 5HT7 receptor transfected in CFO-K1 cells after 30 mins by liquid scintillation spectrometry | B | 8.4 | pKd | 3.98 | nM | Kd | Eur J Med Chem (2014) 85: 716-726 [PMID:25128671] |
ChEMBL | Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor | B | 8.09 | pKi | 8.1 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]5-HT from recombinant human 5-HT7 receptor expressed in African green monkey COS7 cells | B | 8.1 | pKi | 7.94 | nM | Ki | Eur J Med Chem (2019) 183: 111705-111705 [PMID:31581003] |
ChEMBL | Displacement of [3H]D-lysergic acid diethylamide from 5HT7R (unknown origin) expressed in HEK293 cell membranes incubated for 1.5 hrs in absence of light by liquid scintillation counting | B | 8.22 | pKi | 6 | nM | Ki | Eur J Med Chem (2016) 123: 180-190 [PMID:27475109] |
ChEMBL | Binding affinity of compound towards rodent 5-hydroxytryptamine 7 receptor | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 7 human receptors | B | 8.5 | pKi | 3.16 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Displacement of [3H]-5-HT from human 5-HT7 receptor expressed in CHOK1 cell membranes after 30 mins by liquid scintillation spectrometry | B | 8.67 | pKi | 2.12 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 4052-4056 [PMID:27396505] |
ChEMBL | Displacement of [3H]5-CT from human recombinant 5-HT7A receptor expressed in HEK cells by radioligand completion assay | B | 8.68 | pKi | 2.1 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
ChEMBL | Displacement of [3H]5-HT from human 5-HT7 receptor expressed in HEK293 cells after 30 mins by microbeta counting analysis | B | 8.85 | pKi | 1.4 | nM | Ki | Eur J Med Chem (2014) 80: 8-35 [PMID:24763360] |
ChEMBL | Displacement of [3H]LSD from human 5-HT7 receptor expressed in CHO cells | B | 9.1 | pKi | 0.8 | nM | Ki | Eur J Med Chem (2015) 92: 221-235 [PMID:25557493] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells | B | 9.1 | pKi | 0.8 | nM | Ki | J Med Chem (2014) 57: 4543-4557 [PMID:24805037] |
GtoPdb | - | - | 9.6 | pKi | - | - | - |
Biochem Pharmacol (2003) 65: 435-40 [PMID:12527336]; Naunyn Schmiedebergs Arch Pharmacol (2001) 363: 620-32 [PMID:11414657]; Br J Pharmacol (1997) 122: 126-32 [PMID:9298538]; J Biol Chem (1993) 268: 23422-6 [PMID:8226867]; Br J Pharmacol (1998) 124: 1300-6 [PMID:9720804] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT7 receptor | B | 9.66 | pKi | 0.22 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 9.77 | pKi | 0.17 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]LSD from human 5HT7 receptor | B | 9.89 | pKi | 0.13 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Binding affinity to human 5-HT7 receptor by radioligand displacement assay | B | 9.96 | pKi | 0.11 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells | B | 8.59 | pIC50 | 2.55 | nM | IC50 | J Nat Prod (2003) 66: 535-537 [PMID:12713409] |
ChEMBL | Inhibition of human 5HT7 receptor | B | 8.82 | pIC50 | 1.5 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT7 receptor | B | 9.21 | pIC50 | 0.61 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Binding affinity to human 5-HT7 receptor by radioligand displacement assay | B | 9.31 | pIC50 | 0.49 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 9.33 | pIC50 | 0.47 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Binding affinity to human 5-HT7 receptor by radioligand displacement assay | B | 9.54 | pIC50 | 0.29 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells | B | 9.6 | pIC50 | 0.25 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells measured after 120 mins by scintillation counting method | B | 9.6 | pIC50 | 0.25 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Agonist activity at 5-HT7R (unknown origin) transfected in HEK293 cells expressing tTA-dependent luciferase reporter and beta arrestin 2-TEV fusion gene assessed as beta arrestin recruitment incubated for 22 hrs by Tango assay | F | 6.95 | pEC50 | 112.2 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at 5-HT7R (unknown origin) transfected in HEK293 cells expressing tTA-dependent luciferase reporter and beta arrestin 2-TEV fusion gene assessed as beta arrestin recruitment incubated for 22 hrs by Tango assay | F | 6.96 | pEC50 | 110 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 Hunter cell incubated for 30 to 60 mins by hit-hunter cAMP assay based chemiluminescence analysis | F | 7.15 | pEC50 | 70 | nM | EC50 | Bioorg Med Chem (2020) 28: 115578-115578 [PMID:32631561] |
ChEMBL | Agonist activity at tTA containing TCS cleavage site-fused 5-HT7 receptor (unknown origin) expressed in tTA-dependent luciferase reporter/TEV-fused beta-arrestin2 expressing HTLA cells assessed as induction of beta-arrestin2 recruitment after 22 hrs by Tango assay | F | 7.32 | pEC50 | 48 | nM | EC50 | J Med Chem (2018) 61: 7218-7233 [PMID:30028132] |
ChEMBL | Agonist activity at tTA containing TCS cleavage site-fused 5-HT7 receptor (unknown origin) expressed in tTA-dependent luciferase reporter/TEV-fused beta-arrestin2 expressing HTLA cells assessed as induction of beta-arrestin2 recruitment after 22 hrs by Tango assay | F | 7.32 | pEC50 | 47.86 | nM | EC50 | J Med Chem (2018) 61: 7218-7233 [PMID:30028132] |
ChEMBL | Agonist activity at human 5-HT7 expressed in HEK-293 cells assessed as increase in cAMP level after 45 mins by HTRF assay | F | 7.77 | pEC50 | 17 | nM | EC50 | J Med Chem (2014) 57: 6879-6884 [PMID:25073094] |
ChEMBL | Agonist activity at human recombinant 5HT7 receptor expressed in CHOK1 cells assessed as increase in cAMP levels by HTRF assay | F | 7.82 | pEC50 | 15 | nM | EC50 | J Med Chem (2009) 52: 2384-2392 [PMID:19326916] |
ChEMBL | Agonist activity at human 5-HT7R transfected in HEK293 cells assessed as Gs-mediated cAMP accumulation incubated for 30 mins by microplate reader analysis | F | 8.03 | pEC50 | 9.33 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at human 5-HT7 receptor expressed in CHO-K1 cells assessed as increase in serotonin-induced cAMP level after 1 hr by TR-FRET assay | F | 8.15 | pEC50 | 7 | nM | EC50 | Bioorg Med Chem Lett (2018) 28: 2039-2049 [PMID:29730027] |
ChEMBL | Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay | F | 8.24 | pEC50 | 5.8 | nM | EC50 | Eur J Med Chem (2016) 123: 180-190 [PMID:27475109] |
ChEMBL | Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay | F | 8.24 | pEC50 | 5.75 | nM | EC50 | Eur J Med Chem (2016) 123: 180-190 [PMID:27475109] |
ChEMBL | Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 cells by LANCE TR-FRET assay | B | 8.24 | pEC50 | 5.7 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 cells by LANCE TR-FRET assay | B | 8.27 | pEC50 | 5.37 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Agonist activity at human 5-HT7R transfected in HEK293 cells assessed as Gs-mediated cAMP accumulation incubated for 30 mins by microplate reader analysis | F | 8.35 | pEC50 | 4.5 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at human 5-HT7A receptor expressed in HEK cell membranes incubated for 20 mins by cAMP functional assay | F | 8.44 | pEC50 | 3.66 | nM | EC50 | Eur J Med Chem (2021) 214: 113243-113243 [PMID:33582388] |
5-HT7 receptor in Mouse [GtoPdb: 12] [UniProtKB: P32304] | ||||||||
GtoPdb | - | - | 8.3 | pKi | - | - | - | Mol Pharmacol (1993) 44: 229-36 [PMID:8394987] |
5-HT7 receptor/Serotonin 7 (5-HT7) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3223] [GtoPdb: 12] [UniProtKB: P32305] | ||||||||
ChEMBL | Binding affinity towards rat 5-hydroxytryptamine 7 receptor | B | 8 | pKi | 10 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]LSD from rat recombinant 5HT7 receptor expressed in HEK293 cells at 10 uM | B | 8.13 | pKi | 7.33 | nM | Ki | Bioorg Med Chem (2007) 15: 5316-5321 [PMID:17517509] |
GtoPdb | - | - | 9.2 | pKi | - | - | - |
J Biol Chem (1993) 268: 18200-4 [PMID:8394362]; Proc Natl Acad Sci USA (1993) 90: 8547-51 [PMID:8397408] |
ChEMBL | Binding affinity at rat 5-hydroxytryptamine 7 receptor. | B | 9.22 | pKi | 0.6 | nM | Ki | J Med Chem (2003) 46: 5365-5374 [PMID:14640545] |
SERT/Serotonin transporter in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL313] [GtoPdb: 928] [UniProtKB: P31652] | ||||||||
ChEMBL | Ability to displace [3H]paroxetine bound to Serotonin transporter receptor in rat forebrain | B | 6.13 | pKi | 740 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Binding affinity towards Serotonin transporter was determined in rat forebrain membrane | B | 6.13 | pKi | 740 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
Organic cation transporter 3/Solute carrier family 22 member 3 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1770033] [GtoPdb: 1021] [UniProtKB: O88446] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells | F | 4.01 | pIC50 | 97000 | nM | IC50 | J Biol Chem (1998) 273: 32776-32786 [PMID:9830022] |
Vesicular monoamine transporter 2/Synaptic vesicular amine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1893] [GtoPdb: 1012] [UniProtKB: Q05940] | ||||||||
ChEMBL | Displacement of [3H]reserpine from human VMAT2 expressed in HEK293 cell membranes incubated for 60 mins by scintillation counting method | B | 5.11 | pKi | 7690 | nM | Ki | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
ChEMBL | Displacement of [3H](+)-syn-Ethyl 1-(2-(2,4-Dioxo-1,2-dihydroquinazolin-3(4H)-yl)ethyl)-4-(4-fluorophenyl)piperidine-3-carboxylate from human VMAT2 expressed in HEK293 cell membranes incubated for 60 mins by scintillation counting method | B | 5.64 | pKi | 2290 | nM | Ki | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
ChEMBL | Inhibition of human VMAT2 expressed in HEK293 cell membranes assessed as reduction in [3H[-5HT uptake pre-incubated for 10 mins before [3H[-5HT addition and measured after 6 mins | B | 5.84 | pIC50 | 1430 | nM | IC50 | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
Vesicular monoamine transporter 2/Synaptic vesicular amine transporter in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295886] [GtoPdb: 1012] [UniProtKB: Q8BRU6] | ||||||||
ChEMBL | Inhibition of VMAT2 in C57Bl/6J mouse striatal membranes assessed as reduction in [3H[-5HT uptake pre-incubated for 10 mins before [3H[-5HT addition and measured after 8 mins | B | 7.01 | pIC50 | 98 | nM | IC50 | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
TA1 receptor/Trace amine-associated receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5857] [GtoPdb: 364] [UniProtKB: Q96RJ0] | ||||||||
ChEMBL | Agonist activity at recombinant human TAAR1 expressed in CHO-K1 cells assessed as increase in intracellular cAMP incubated for 30 mins by HTRF analysis | F | 4.45 | pEC50 | 35100 | nM | EC50 | ACS Med Chem Lett (2022) 13: 92-98 [PMID:35047111] |
D5 receptor in Human [GtoPdb: 218] [UniProtKB: P21918] | ||||||||
GtoPdb | - | - | 5.5 | pKi | - | - | - | Nature (1991) 350: 614-9 [PMID:1826762] |
5-HT3AB in Human [GtoPdb: 378] | ||||||||
GtoPdb | - | - | 6 | pKi | - | - | - | Neuropharmacology (2001) 41: 282-4 [PMID:11489465] |
GtoPdb | - | - | 5.8 | pEC50 | - | - | - |
Nature (1999) 397: 359-63 [PMID:9950429]; J Biol Chem (1999) 274: 30799-810 [PMID:10521471]; J Pharmacol Exp Ther (2005) 315: 771-6 [PMID:16081679]; Mol Pharmacol (2000) 57: 1114-22 [PMID:10825381] |
5-HT3A in Human [GtoPdb: 379] | ||||||||
GtoPdb | - | - | 6.9 | pKi | - | - | - |
Mol Pharmacol (1998) 53: 202-12 [PMID:9463477]; Neuropharmacology (2001) 41: 282-4 [PMID:11489465]; Br J Pharmacol (1996) 118: 1237-45 [PMID:8818349]; Eur J Pharmacol (2000) 409: 195-201 [PMID:11104834] |
GtoPdb | - | - | 6.4 | pEC50 | - | - | - |
Mol Pharmacol (1995) 48: 1054-62 [PMID:8848005]; Mol Pharmacol (2000) 57: 1114-22 [PMID:10825381]; Nature (1999) 397: 359-63 [PMID:9950429]; J Biol Chem (1999) 274: 30799-810 [PMID:10521471]; Mol Pharmacol (1998) 53: 202-12 [PMID:9463477]; Mol Pharmacol (1995) 48: 407-16 [PMID:7565620]; J Pharmacol Exp Ther (2005) 315: 771-6 [PMID:16081679] |
Proton-coupled Amino acid Transporter 1 in Human [GtoPdb: 1161] [UniProtKB: Q7Z2H8] | ||||||||
GtoPdb | - | - | 2.2 | pKi | 5700000 | nM | Ki | FASEB J (2005) 19: 1468-73 [PMID:16126914] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]